Airway inflammation in chronic obstructive pulmonary disease (COPD): a true paradox

References

• Schluger NW, Koppaka R. Lung disease in a global context. A call for public health action. Ann Am Thorac Soc. 2014;11(3):407–416.
   PubMedGoogle Scholar
• Pesci A, Balbi B, Majori M, et al. Inflammatory cells and mediators in bronchial lavage of patients with chronic obstructive pulmonary disease. Eur Respir J. 1998;12(2):380–386.
   PubMed Web of Science ®Google Scholar
• Rutgers SR, Timens W, Kaufmann HF, et al. Comparison of induced sputum with bronchial wash, bronchoalveolar lavage and bronchial biopsies in COPD. Eur Respir J. 2000;15(1):109–115.
   PubMed Web of Science ®Google Scholar
• Pesci A, Majori M, Cuomo A, et al. Neutrophils infiltrating bronchial epithelium in chronic obstructive pulmonary disease. Respir Med. 1998;92(6):863–870.
   PubMed Web of Science ®Google Scholar
• Di Stefano A, Capelli A, Lusuardi M, et al. Severity of airflow limitation is associated with severity of airway inflammation in smokers. Am J Respir Crit Care Med. 1998;158(4):1277–1285.
   PubMed Web of Science ®Google Scholar
• Di Stefano A, Capelli A, Lusuardi M, et al. Decreased T lymphocyte infiltration in bronchial biopsies of subjects with severe chronic obstructive pulmonary disease. Clin Experimental Allergy: Journal Br Soc Allergy Clin Immunol. 2001;31(6):893–902.
   PubMed Web of Science ®Google Scholar
• Saetta M, Baraldo S, Corbino L, et al. CD8+ve cells in the lungs of smokers with chronic obstructive pulmonary disease. Am J Respir Crit Care Med. 1999;160(2):711–717.
   PubMed Web of Science ®Google Scholar
• Lacoste J-Y, Bousquet J, Chanez P, et al. Eosinophilic and neutrophilic inflammation in asthma, chronic bronchitis, and chronic obstructive pulmonary disease. J Allergy Clin Immunol. 1993;92(4):537–548.
   PubMed Web of Science ®Google Scholar
• Traves SL, Culpitt SV, Russell REK, et al. Increased levels of the chemokines GROα and MCP-1 in sputum samples from patients with COPD. Thorax. 2002;57(7):590–595.
   PubMed Web of Science ®Google Scholar
• Leckie MJ, Jenkins GR, Khan J, et al. Sputum T lymphocytes in asthma, COPD and healthy subjects have the phenotype of activated intraepithelial T cells (CD69+ CD103+). Thorax. 2003;58(1):23–29.
   PubMed Web of Science ®Google Scholar
• Profita M, Sala A, Bonanno A, et al. Chronic obstructive pulmonary disease and neutrophil infiltration: role of cigarette smoke and cyclooxygenase products. Am J Physiol Lung Cell Mol Physiol. 2010;298(2):L261–L9.
   PubMed Web of Science ®Google Scholar
• Bhowmik A, Seemungal TAR, Sapsford RJ, et al. Relation of sputum inflammatory markers to symptoms and lung function changes in COPD exacerbations. Thorax. 2000;55(2):114–120.
   PubMed Web of Science ®Google Scholar
• Mercer BA, Lemaître V, Powell CA, et al. The epithelial cell in lung health and emphysema pathogenesis. Curr Respir Med Rev. 2006;2(2):101–142.
   PubMedGoogle Scholar
• Sohal SS, Reid D, Soltani A, et al. Changes in airway histone deacetylase2 in smokers and COPD with inhaled corticosteroids: a randomized controlled trial. Plos One. 2013;8(5):e64833.
   PubMed Web of Science ®Google Scholar
• Sohal SS, Reid D, Soltani A, et al. Reticular basement membrane fragmentation and potential epithelial mesenchymal transition is exaggerated in the airways of smokers with chronic obstructive pulmonary disease. Respirology. 2010;15(6):930–938.
   PubMed Web of Science ®Google Scholar
• Eapen MS, McAlinden KD, Tan D, et al. Inflammation paradox – a detailed analysis of inflammatory profile in the large and small airway wall in mild to moderate chronic obstructive pulmonary disease (COPD) patients. C35 innate immune mechanisms in COPD. American Journal of Respiratory and Critical Care Medicine. 2016;193:A4895.
   Web of Science ®Google Scholar
• Shaykhiev R, Crystal RG. Innate immunity and chronic obstructive pulmonary disease: a mini-review. Gerontology. 2013;59(6):481–489.
   PubMed Web of Science ®Google Scholar
• Brusselle GG, Joos GF, Bracke KR. New insights into the immunology of chronic obstructive pulmonary disease. Lancet (London, England). 2011;378(9795):1015–1026.
   PubMed Web of Science ®Google Scholar
• Stanescu D, Sanna A, Veriter C, et al. Airways obstruction, chronic expectoration, and rapid decline of FEV1 in smokers are associated with increased levels of sputum neutrophils. Thorax. 1996;51(3):267–271.
   PubMed Web of Science ®Google Scholar
• O’Donnell R, Peebles C, Ward J, et al. Relationship between peripheral airway dysfunction, airway obstruction, and neutrophilic inflammation in COPD. Thorax. 2004;59(10):837–842.
   PubMed Web of Science ®Google Scholar
• Keatings VM, Collins PD, Scott DM, et al. Differences in interleukin-8 and tumor necrosis factor-alpha in induced sputum from patients with chronic obstructive pulmonary disease or asthma. Am J Respir Crit Care Med. 1996;153(2):530–534.
   PubMed Web of Science ®Google Scholar
• Saetta M, Di Stefano A, Maestrelli P, et al. Activated T-lymphocytes and macrophages in bronchial mucosa of subjects with chronic bronchitis. Am Rev Respir Dis. 1993;147(2):301–306.
   PubMed Web of Science ®Google Scholar
• O’Shaughnessy TC, Ansari TW, Barnes NC, et al. Inflammation in bronchial biopsies of subjects with chronic bronchitis: inverse relationship of CD8+ T lymphocytes with FEV1. Am J Respir Crit Care Med. 1997;155(3):852–857.
   PubMed Web of Science ®Google Scholar
• Hogg JC, Chu F, Utokaparch S, et al. The nature of small-airway obstruction in chronic obstructive pulmonary disease. New England J Med. 2004;350(26):2645–2653.
   PubMed Web of Science ®Google Scholar
• Lams BEA, Sousa AR, Rees PJ, et al. Immunopathology of the small-airway submucosa in smokers with and without chronic obstructive pulmonary disease. Am J Respir Crit Care Med. 1998;158(5):1518–1523.
   PubMed Web of Science ®Google Scholar
• Isajevs S, Taivans I, Svirina D, et al. Patterns of inflammatory responses in large and small airways in smokers with and without chronic obstructive pulmonary disease. Respiration. 2011;81(5):362–371.
   PubMed Web of Science ®Google Scholar
• Eapen MS, McAlinden K, Tan D, et al. Profiling cellular and inflammatory changes in the airway wall of mild to moderate COPD. Respirology. 2017;22(6):1125–1132.
   PubMed Web of Science ®Google Scholar
• Hogg JC, Paré PD, Hackett T-L. The contribution of small airway obstruction to the pathogenesis of chronic obstructive pulmonary disease. Physiol Rev. 2017;97(2):529–552.
   PubMed Web of Science ®Google Scholar
• Gunay E, Sarinc Ulasli S, Akar O, et al. Neutrophil-to-lymphocyte ratio in chronic obstructive pulmonary disease: a retrospective study. Inflammation. 2014;37(2):374–380.
   PubMed Web of Science ®Google Scholar
• Yoshikawa T, Dent G, Ward J, et al. Impaired neutrophil chemotaxis in chronic obstructive pulmonary disease. Am J Respir Crit Care Med. 2007;175(5):473–479.
   PubMed Web of Science ®Google Scholar
• Sapey E, Stockley JA, Greenwood H, et al. Behavioral and structural differences in migrating peripheral neutrophils from patients with chronic obstructive pulmonary disease. Am J Respir Crit Care Med. 2011;183(9):1176–1186.
   PubMed Web of Science ®Google Scholar
• Beckett EL, Stevens RL, Jarnicki AG, et al. A short-term model of COPD identifies a role for mast cell tryptase. J Allergy Clin Immunol. 2013;131(3):752–762.
   PubMed Web of Science ®Google Scholar
• Churg A, Zay K, Shay S, et al. Acute cigarette smoke-induced connective tissue breakdown requires both neutrophils and macrophage metalloelastase in mice. Am J Respir Cell Mol Biol. 2002;27(3):368–374.
   PubMed Web of Science ®Google Scholar
• Wright JL, Churg A. Animal models of cigarette smoke-induced chronic obstructive pulmonary disease. Expert Rev Respir Med. 2010;4(6):723–734.
   PubMedGoogle Scholar
• Lappalainen U, Whitsett JA, Wert SE, et al. Interleukin-1beta causes pulmonary inflammation, emphysema, and airway remodeling in the adult murine lung. Am J Respir Cell Mol Biol. 2005;32(4):311–318.
   PubMed Web of Science ®Google Scholar
• Braber S, Henricks PAJ, Nijkamp FP, et al. Inflammatory changes in the airways of mice caused by cigarette smoke exposure are only partially reversed after smoking cessation. Respir Res. 2010;11(1):99.
   PubMed Web of Science ®Google Scholar
• March TH, Wilder JA, Esparza DC, et al. Modulators of cigarette smoke-induced pulmonary emphysema in A/J mice. Toxicological Sci. 2006;92(2):545–559.
   PubMed Web of Science ®Google Scholar
• Nicod LP. Pulmonary defence mechanisms. Respiration. 1999;66(1):2–11.
   PubMed Web of Science ®Google Scholar
• Ambarus CA, Krausz S, van Eijk M, et al. Systematic validation of specific phenotypic markers for in vitro polarized human macrophages. J Immunol Methods. 2012;375(1–2):196–206.
   PubMed Web of Science ®Google Scholar
• Kaku Y, Imaoka H, Morimatsu Y, et al. Overexpression of CD163, CD204 and CD206 on alveolar macrophages in the lungs of patients with severe chronic obstructive pulmonary disease. PLoS One. 2014;9(1):e87400.
   PubMed Web of Science ®Google Scholar
• Kuschner W, D’Alessandro A, Wong H, et al. Dose-dependent cigarette smoking-related inflammatory responses in healthy adults. Eur Respir J. 1996;9(10):1989–1994.
   PubMed Web of Science ®Google Scholar
• Rutgers S, Postma D, Ten H, et al. Ongoing airway inflammation in patients with COPD who do not currently smoke. Thorax. 2000;55(1):12–18.
   PubMed Web of Science ®Google Scholar
• Lams B, Sousa A, Rees P, et al. Subepithelial immunopathology of the large airways in smokers with and without chronic obstructive pulmonary disease. Eur Respir J. 2000;15(3):512–516.
   PubMed Web of Science ®Google Scholar
• Utokaparch S, Sze MA, Gosselink JV, et al. Respiratory viral detection and small airway inflammation in lung tissue of patients with stable, mild COPD. Copd. 2014;11(2):197–203.
   PubMedGoogle Scholar
• Sohal S, Eapen M, Tan D, et al. Is central airway inflammation really a feature of mild-moderate chronic obstructive pulmonary disease (COPD)?. American Journal of Respiratory and Critical Care Medicine. 2015;191:A2870.
   Google Scholar
• Caramori G, Romagnoli M, Casolari P, et al. Nuclear localisation of p65 in sputum macrophages but not in sputum neutrophils during COPD exacerbations. Thorax. 2003;58(4):348–351.
   PubMed Web of Science ®Google Scholar
• Park JM, Greten FR, Wong A, et al. Signaling pathways and genes that inhibit pathogen-induced macrophage apoptosis–CREB and NF-kappaB as key regulators. Immunity. 2005;23(3):319–329.
   PubMed Web of Science ®Google Scholar
• Russell RE, Thorley A, Culpitt SV, et al. Alveolar macrophage-mediated elastolysis: roles of matrix metalloproteinases, cysteine, and serine proteases. Am J Physiol Lung Cell Mol Physiol. 2002;283(4):L867–73.
   PubMed Web of Science ®Google Scholar
• Mukaro VR, Hodge S. Airway clearance of apoptotic cells in COPD. Curr Drug Targets. 2011;12(4):460–468.
   PubMed Web of Science ®Google Scholar
• Mantovani A, Sica A, Sozzani S, et al. The chemokine system in diverse forms of macrophage activation and polarization. Trends Immunol. 2004;25(12):677–686.
   PubMed Web of Science ®Google Scholar
• Mosmann TR, Cherwinski H, Bond MW, et al. Two types of murine helper T cell clone. I. Definition according to profiles of lymphokine activities and secreted proteins. J Immunol (Baltimore, Md: 1950). 1986;136(7):2348–2357.
   PubMed Web of Science ®Google Scholar
• Martinez FO, Gordon S. The M1 and M2 paradigm of macrophage activation: time for reassessment. F1000Prime Rep. 2014;6:13.
   PubMedGoogle Scholar
• Benson RC, Hardy KA, Morris CR. Arginase and arginine dysregulation in asthma. J Allergy (Cairo). 2011;2011:12.
   Google Scholar
• McAlinden KD, Weston S, Mahmood MQ, et al. Macrophage phenotype changes within the small airway wall in smokers and chronic obstructive pulmonary disease (COPD). B43 COPD: Phenotypes and Clinical Outcomes. American Journal of Respiratory and Critical Care Medicine 2016;193:A3513.
   Web of Science ®Google Scholar
• Ohar JA, Hamilton RF Jr., Zheng S, et al. COPD is associated with a macrophage scavenger receptor-1 gene sequence variation. Chest. 2010;137(5):1098–1107.
   PubMed Web of Science ®Google Scholar
• Shaykhiev R, Krause A, Salit J, et al. Smoking-dependent reprogramming of alveolar macrophage polarization: implication for pathogenesis of chronic obstructive pulmonary disease. J Immunol (Baltimore, Md: 1950). 2009;183(4):2867–2883.
   PubMed Web of Science ®Google Scholar
• Ichinose M, Sugiura H, Yamagata S, et al. Increase in reactive nitrogen species production in chronic obstructive pulmonary disease airways. Am J Respir Crit Care Med. 2000;162(2 Pt 1):701–706.
   PubMed Web of Science ®Google Scholar
• Balzano G, Stefanelli F, Iorio C, et al. Eosinophilic inflammation in stable chronic obstructive pulmonary disease. Relationship with neutrophils and airway function. Am J Respir Crit Care Med. 1999;160(5 Pt 1):1486–1492.
   PubMed Web of Science ®Google Scholar
• Singh D, Kolsum U, Brightling CE, et al. Eosinophilic inflammation in COPD: prevalence and clinical characteristics. Eur Respir J. 2014;44:1697–1700.
   PubMed Web of Science ®Google Scholar
• Prajakta J, Michiko M, Anders B, et al. Mapping of eosinophil and basophils in COPD lung tissues. B37 TELL ME WHY: COPD PATHOGENESIS. American Journal of Respiratory and Critical Care Medicine. 2015;191:A2876.
   Web of Science ®Google Scholar
• Bafadhel M, McKenna S, Terry S, et al. Acute exacerbations of chronic obstructive pulmonary disease: identification of biologic clusters and their biomarkers. Am J Respir Crit Care Med. 2011;184(6):662–671.
   PubMed Web of Science ®Google Scholar
• Grashoff WF, Sont JK, Sterk PJ, et al. Chronic obstructive pulmonary disease: role of bronchiolar mast cells and macrophages. Am J Pathol. 1997;151(6):1785–1790.
   PubMed Web of Science ®Google Scholar
• Ekberg-Jansson A, Amin K, Bake B, et al. Bronchial mucosal mast cells in asymptomatic smokers relation to structure, lung function and emphysema. Respir Med. 2005;99(1):75–83.
   PubMed Web of Science ®Google Scholar
• Soltani A, Ewe YP, Lim ZS, et al. Mast cells in COPD airways: relationship to bronchodilator responsiveness and angiogenesis. Eur Respir J. 2012;39(6):1361–1367.
   PubMed Web of Science ®Google Scholar
• Andersson CK, Mori M, Bjermer L, et al. Alterations in lung mast cell populations in patients with chronic obstructive pulmonary disease. Am J Respir Crit Care Med. 2010;181(3):206–217.
   PubMed Web of Science ®Google Scholar
• Gosman MM, Postma DS, Vonk JM, et al. Association of mast cells with lung function in chronic obstructive pulmonary disease. Respir Res. 2008;9(1):64.
   PubMed Web of Science ®Google Scholar
• McKendry RT, Spalluto CM, Burke H, et al. Dysregulation of antiviral function of CD8(+) T cells in the chronic obstructive pulmonary disease lung. Role of the PD-1–PD-L1 axis. Am J Respir Crit Care Med. 2016;193(6):642–651.
   PubMed Web of Science ®Google Scholar
• Tsoumakidou M, Koutsopoulos AV, Tzanakis N, et al. Decreased small airway and alveolar CD83+ dendritic cells in COPD. Chest. 2009;136(3):726–733.
   PubMed Web of Science ®Google Scholar
• Tsoumakidou M, Bouloukaki I, Koutala H, et al. Decreased sputum mature dendritic cells in healthy smokers and patients with chronic obstructive pulmonary disease. Int Arch Allergy Immunol. 2009;150(4):389–397.
   PubMed Web of Science ®Google Scholar
• Vassallo R, Walters PR, Lamont J, et al. Cigarette smoke promotes dendritic cell accumulation in COPD; a Lung Tissue Research Consortium study. Respir Res. 2010;11:45.
   PubMed Web of Science ®Google Scholar
• Demedts IK, Bracke KR, Van Pottelberge G, et al. Accumulation of dendritic cells and increased CCL20 levels in the airways of patients with chronic obstructive pulmonary disease. Am J Respir Crit Care Med. 2007;175(10):998–1005.
   PubMed Web of Science ®Google Scholar
• Van Pottelberge GR, Bracke KR, Demedts IK, et al. Selective accumulation of Langerhans-type dendritic cells in small airways of patients with COPD. Respir Res. 2010;11(1):35.
   PubMed Web of Science ®Google Scholar
• Sohal SS, Reid D, Soltani A, et al. Evaluation of epithelial mesenchymal transition in patients with chronic obstructive pulmonary disease. Respir Res. 2011;12(1):1–7.
   PubMed Web of Science ®Google Scholar
• Hashimoto M, Yanagisawa H, Minagawa S, et al. A critical role for dendritic cells in the evolution of IL-1β-mediated murine airway disease. J Immunol (Baltimore, Md: 1950). 2015;194(8):3962–3969.
   PubMed Web of Science ®Google Scholar
• Mikko M, Forsslund H, Cui L, et al. Increased intraepithelial (CD103+) CD8+ T cells in the airways of smokers with and without chronic obstructive pulmonary disease. Immunobiology. 2013;218(2):225–231.
   PubMed Web of Science ®Google Scholar
• Freeman CM, Stolberg VR, Crudgington S, et al. Human CD56+ cytotoxic lung lymphocytes kill autologous lung cells in chronic obstructive pulmonary disease. PLoS One. 2014;9(7):e103840.
   PubMed Web of Science ®Google Scholar
• Freeman CM, McCubbrey AL, Crudgington S, et al. Basal gene expression by lung CD4+ T cells in chronic obstructive pulmonary disease identifies independent molecular correlates of airflow obstruction and emphysema extent. PLoS One. 2014;9(5):e96421.
   PubMed Web of Science ®Google Scholar
• Forsslund H, Mikko M, Karimi R, et al. Distribution of T-cell subsets in BAL fluid of patients with mild to moderate COPD depends on current smoking status and not airway obstruction. Chest. 2014;145(4):711–722.
   PubMed Web of Science ®Google Scholar
• Urboniene D, Babusyte A, Lotvall J, et al. Distribution of gammadelta and other T-lymphocyte subsets in patients with chronic obstructive pulmonary disease and asthma. Respir Med. 2013;107(3):413–423.
   PubMed Web of Science ®Google Scholar
• Chang Y, Nadigel J, Boulais N, et al. CD8 positive T cells express IL-17 in patients with chronic obstructive pulmonary disease. Respir Res. 2011;12:43.
   PubMed Web of Science ®Google Scholar
• Mathai RT, Peripheral Blood BS. T-cell populations in COPD, asymptomatic smokers and healthy non-smokers in Indian subpopulation – a pilot study. J Clin Diagn Res. 2013;7(6):1109–1113.
   PubMedGoogle Scholar
• Grundy S, Plumb J, Lea S, et al. Down regulation of T cell receptor expression in COPD pulmonary CD8 cells. PLoS One. 2013;8:8.
   Web of Science ®Google Scholar
• Freeman CM, Martinez FJ, Han MK, et al. Lung CD8+ T cells in COPD have increased expression of bacterial TLRs. Respir Res. 2013;14:13.
   PubMed Web of Science ®Google Scholar
• Hodge G, Reynolds PN, Holmes M, et al. Differential expression of pro-inflammatory cytokines in intra-epithelial T cells between trachea and bronchi distinguishes severity of COPD. Cytokine. 2012;60(3):843–848.
   PubMed Web of Science ®Google Scholar
• Hodge G, Mukaro V, Reynolds PN, et al. Role of increased CD8/CD28(null) T cells and alternative co-stimulatory molecules in chronic obstructive pulmonary disease. Clin Exp Immunol. 2011;166(1):94–102.
   PubMed Web of Science ®Google Scholar
• Roos-Engstrand E, Pourazar J, Behndig AF, et al. Cytotoxic T cells expressing the co-stimulatory receptor NKG2 D are increased in cigarette smoking and COPD. Respir Res. 2010;11:128.
   PubMed Web of Science ®Google Scholar
• Olloquequi J, Ferrer J, Montes JF, et al. Differential lymphocyte infiltration in small airways and lung parenchyma in COPD patients. Respir Med. 2010;104(9):1310–1318.
   PubMed Web of Science ®Google Scholar
• Freeman CM, Han MK, Martinez FJ, et al. Cytotoxic potential of lung CD8(+) T cells increases with chronic obstructive pulmonary disease severity and with in vitro stimulation by IL-18 or IL-15. J Immunol. 2010;184(11):6504–6513.
   PubMed Web of Science ®Google Scholar
• Lofdahl MJ, Roos-Engstrand E, Pourazar J, et al. Increased intraepithelial T-cells in stable COPD. Respir Med. 2008;102(12):1812–1818.
   PubMed Web of Science ®Google Scholar
• Glader P, Von Wachenfeldt K, Lofdahl CG. Systemic CD4+ T-cell activation is correlated with FEV1 in smokers. Respir Med. 2006;100(6):1088–1093.
   PubMed Web of Science ®Google Scholar
• Gosman MME, Willemse BWM, Jansen DF, et al. Increased number of B-cells in bronchial biopsies in COPD. Eur Respir J. 2006;27(1):60–64.
   PubMed Web of Science ®Google Scholar
• Polverino F, Cosio BG, Pons J, et al. B cell–activating factor. An orchestrator of lymphoid follicles in severe chronic obstructive pulmonary disease. Am J Respir Crit Care Med. 2015;192(6):695–705.
   PubMed Web of Science ®Google Scholar
• Faner R, Cruz T, Casserras T, et al. Network analysis of lung transcriptomics reveals a distinct B-cell signature in emphysema. Am J Respir Crit Care Med. 2016;193(11):1242–1253.
   PubMed Web of Science ®Google Scholar
• Lee J, Machin M, Russell KE, et al. Corticosteroid modulation of immunoglobulin expression and B-cell function in COPD. Faseb J. 2016;30(5):2014–2026.
   PubMed Web of Science ®Google Scholar
• Cazzola M, Matera MG. IL-17 in chronic obstructive pulmonary disease. Expert Rev Respir Med. 2012;6(2):135–138.
   PubMed Web of Science ®Google Scholar
• Di Stefano A, Caramori G, Gnemmi I, et al. T helper type 17-related cytokine expression is increased in the bronchial mucosa of stable chronic obstructive pulmonary disease patients. Clin Exp Immunol. 2009;157(2):316–324.
   PubMed Web of Science ®Google Scholar
• Zhang L, Cheng Z, Liu W, et al. Expression of interleukin (IL)-10, IL-17A and IL-22 in serum and sputum of stable chronic obstructive pulmonary disease patients. COPD: J Chronic Obstructive Pulm Dis. 2013;10(4):459–465.
   Web of Science ®Google Scholar
• Vargas-Rojas MI, Ramírez-Venegas A, Limón-Camacho L, et al. Increase of Th17 cells in peripheral blood of patients with chronic obstructive pulmonary disease. Respir Med. 2011;105(11):1648–1654.
   PubMed Web of Science ®Google Scholar
• Wang H, Ying H, Wang S, et al. Imbalance of peripheral blood Th17 and Treg responses in patients with chronic obstructive pulmonary disease. Clin Respir J. 2015;9(3):330–341.
   PubMed Web of Science ®Google Scholar
• Li H, Liu Q, Jiang Y, et al. Disruption of Th17/Treg balance in the sputum of patients with chronic obstructive pulmonary disease. Am J Med Sci. 2015;349(5):392–397.
   PubMed Web of Science ®Google Scholar
• Barceló B, Pons J, Ferrer JM, et al. Phenotypic characterisation of T-lymphocytes in COPD: abnormal CD4+CD25+ regulatory T-lymphocyte response to tobacco smoking. Eur Respir J. 2008;31(3):555–562.
   PubMed Web of Science ®Google Scholar
• Roos-Engstrand E, Pourazar J, Behndig AF, et al. Expansion of CD4+CD25+ helper T cells without regulatory function in smoking and COPD. Respir Res. 2011;12:74.
   PubMed Web of Science ®Google Scholar
• Hou J, Sun Y, Hao Y, et al. Imbalance between subpopulations of regulatory T cells in COPD. Thorax. 2013;68(12):1131–1139.
   PubMed Web of Science ®Google Scholar
• Zuo L, He F, Sergakis GG, et al. Interrelated role of cigarette smoking, oxidative stress, and immune response in COPD and corresponding treatments. Am J Physiol Lung Cell Mol Physiol. 2014;307(3):L205–L18.
   PubMed Web of Science ®Google Scholar
• Morlá M, Busquets X, Pons J, et al. Telomere shortening in smokers with and without COPD. Eur Respir J. 2006;27(3):525–528.
   PubMed Web of Science ®Google Scholar
• Ceylan E, Kocyigit A, Gencer M, et al. Increased DNA damage in patients with chronic obstructive pulmonary disease who had once smoked or been exposed to biomass. Respir Med. 2006;100(7):1270–1276.
   PubMed Web of Science ®Google Scholar
• Aoshiba K, Tsuji T, Yamaguchi K, et al. The danger signal plus DNA damage two-hit hypothesis for chronic inflammation in COPD. Eur Respir J. 2013;42(6):1689–1695.
   PubMed Web of Science ®Google Scholar
• Freund A, Orjalo AV, Desprez P-Y, et al. Inflammatory networks during cellular senescence: causes and consequences. Trends Mol Med. 2010;16(5):238–246.
   PubMed Web of Science ®Google Scholar
• McKendry RT, Spalluto CM, Burke H, et al. Dysregulation of antiviral function of CD8+ T cells in the chronic obstructive pulmonary disease lung. Role of the PD-1–PD-L1 axis. Am J Respir Crit Care Med. 2015;193(6):642–651.
   Web of Science ®Google Scholar
• Eapen MS, Tan E, Ward C, et al. Decreased degranulating cells and mast cell population in the small airway wall of mild-moderate copd is indicative of dysfunctional immunity. Tsanz Poster Presentations. Respirology. 2017;22:101–193.
   Google Scholar
• Schroder K, Tschopp J. The inflammasomes. Cell. 2010;140(6):821–832.
   PubMed Web of Science ®Google Scholar
• Kim RY, Pinkerton JW, Gibson PG, et al. Inflammasomes in COPD and neutrophilic asthma. Thorax. 2015;70(12):1199–1201.
   PubMed Web of Science ®Google Scholar
• Di Stefano A, Caramori G, Barczyk A, et al. Innate immunity but not NLRP3 inflammasome activation correlates with severity of stable COPD. Thorax. 2014;69(6):516–524.
   PubMed Web of Science ®Google Scholar
• Ry K, Pinkerton JW, Gibson PG, et al. Inflammasomes in COPD and neutrophilic asthma. Thorax. 2015 Dec;70(12):1199-1201.
   PubMed Web of Science ®Google Scholar
• Franklin BS, Bossaller L, De Nardo D, et al. The adaptor ASC has extracellular and ‘prionoid’ activities that propagate inflammation. Nat Immunol. 2014;15(8):727–737.
   PubMed Web of Science ®Google Scholar
• Zuo L, Lucas K, Fortuna CA, et al. Molecular regulation of toll-like receptors in asthma and COPD. Front Physiol. 2015;6:312.
   PubMed Web of Science ®Google Scholar
• Nadigel J, Préfontaine D, Baglole CJ, et al. Cigarette smoke increases TLR4 and TLR9 expression and induces cytokine production from CD8(+)T cells in chronic obstructive pulmonary disease. Respir Res. 2011;12(1):149.
   PubMed Web of Science ®Google Scholar
• Lee SW, Kim DR, Kim TJ, et al. The association of down-regulated toll-like receptor 4 expression with airflow limitation and emphysema in smokers. Respir Res. 2012;13(1):106.
   PubMed Web of Science ®Google Scholar
• Di Stefano A, Ricciardolo FLM, Caramori G, et al. Bronchial inflammation and bacterial load in stable COPD is associated with TLR4 overexpression. Eur Respir J. 2017;49(5).
   PubMed Web of Science ®Google Scholar
• Puchelle E, Zahm J-M, Tournier J-M, et al. Airway epithelial repair, regeneration, and remodeling after injury in chronic obstructive pulmonary disease. Proc Am Thorac Soc. 2006;3(8):726–733.
   PubMedGoogle Scholar
• Shaykhiev R, Crystal RG. Early events in the pathogenesis of chronic obstructive pulmonary disease. Smoking-induced reprogramming of airway epithelial basal progenitor cells. Ann Am Thorac Soc. 2014;11(Suppl 5):S252–8.
   PubMedGoogle Scholar
• Shaykhiev R, Otaki F, Bonsu P, et al. Cigarette smoking reprograms apical junctional complex molecular architecture in the human airway epithelium in vivo. Cellular Molecular Life Sciences: CMLS. 2011;68(5):877–892.
   PubMed Web of Science ®Google Scholar
• Peters EJ, Morice R, Benner SE, et al. Squamous metaplasia of the bronchial mucosa and its relationship to smoking. Chest. 1993;103(5):1429–1432.
   PubMed Web of Science ®Google Scholar
• Crystal RG. Airway basal cells. The “smoking gun” of chronic obstructive pulmonary disease. Am J Respir Crit Care Med. 2014;190(12):1355–1362.
   PubMed Web of Science ®Google Scholar
• Sohal SS, Hansbro PM, Walters EH. Epithelial mesenchymal transition in COPD, a precursor for epithelial cancers: understanding and translation to early therapy. Ann Am Thorac Soc. 2017.
   PubMedGoogle Scholar
• Jolly MK, Ward C, Eapen MS, et al. Epithelial mesenchymal transition (EMT), a spectrum of states: role in lung development, homeostasis and disease. Developmental Dynamics.n/a-n/a.
   Google Scholar
• Milara J, Peiro T, Serrano A, et al. Epithelial to mesenchymal transition is increased in patients with COPD and induced by cigarette smoke. Thorax. 2013;68(5):410–420.
   PubMed Web of Science ®Google Scholar
• Sohal SS. Chronic obstructive pulmonary disease (COPD) and lung cancer: epithelial mesenchymal transition (EMT), the missing link? EBioMedicine. 2015;2(11):1578–1579.
   PubMed Web of Science ®Google Scholar
• Mahmood MQ, Sohal SS, Shukla SD, et al. Epithelial mesenchymal transition in smokers: large versus small airways and relation to airflow obstruction. Int J Chron Obstruct Pulmon Dis. 2015;10:1515–1524.
   PubMed Web of Science ®Google Scholar
• Mahmood MQ, Reid D, Ward C, et al. Transforming growth factor (TGF) β1 and Smad signalling pathways: a likely key to EMT-associated COPD pathogenesis. Respirology. 2017;22(1):133–140.
   PubMed Web of Science ®Google Scholar
• Sohal SS, Soltani A, Reid D, et al. A randomized controlled trial of inhaled corticosteroids (ICS) on markers of epithelial–mesenchymal transition (EMT) in large airway samples in COPD: an exploratory proof of concept study. Int J Chron Obstruct Pulmon Dis. 2014;9:533–542.
   PubMed Web of Science ®Google Scholar
• Sohal SS, Eapen MS, Ward DC, et al. Epithelial mesenchymal transition (EMT): a necessary new therapeutic target in COPD? American journal of respiratory and critical care medicine.0(ja): null.
   Google Scholar
• Milara J, Peiro T, Serrano A, et al. Roflumilast N-oxide inhibits bronchial epithelial to mesenchymal transition induced by cigarette smoke in smokers with COPD. Pulm Pharmacol Ther. 2014;28(2):138–148.
   PubMed Web of Science ®Google Scholar
• Gohy ST, Hupin C, Fregimilicka C, et al. Imprinting of the COPD airway epithelium for dedifferentiation and mesenchymal transition. Eur Respir J. 2015;45:1258–1272.
   PubMed Web of Science ®Google Scholar
• Wang Q, Wang Y, Zhang Y, et al. The role of uPAR in epithelial-mesenchymal transition in small airway epithelium of patients with chronic obstructive pulmonary disease. Respir Res. 2013;14(1):67.
   PubMed Web of Science ®Google Scholar
• Froidure A, Ladjemi MZ, Pilette C. Interleukin-1α: a key player for epithelial-to-mesenchymal signalling in COPD? Eur Respir J. 2016;48(2):301–304.
   PubMed Web of Science ®Google Scholar
• Osei ET, Noordhoek JA, Hackett TL, et al. Interleukin-1α drives the dysfunctional cross-talk of the airway epithelium and lung fibroblasts in COPD. Eur Respir J. 2016;48(2):359–369.
   PubMed Web of Science ®Google Scholar
• Lofdahl M, Kaarteenaho R, Lappi-Blanco E, et al. Tenascin-C and alpha-smooth muscle actin positive cells are increased in the large airways in patients with COPD. Respir Res. 2011;12:48.
   PubMed Web of Science ®Google Scholar
• Karvonen HM, Lehtonen ST, Harju T, et al. Myofibroblast expression in airways and alveoli is affected by smoking and COPD. Respir Res. 2013;14:84.
   PubMed Web of Science ®Google Scholar
• Hallgren O, Rolandsson S, Andersson-Sjoland A, et al. Enhanced ROCK1 dependent contractility in fibroblast from chronic obstructive pulmonary disease patients. J Transl Med. 2012;10:171.
   PubMed Web of Science ®Google Scholar
• Baarsma HA, Spanjer AI, Haitsma G, et al. Activation of WNT/beta-catenin signaling in pulmonary fibroblasts by TGF-beta(1) is increased in chronic obstructive pulmonary disease. PLoS One. 2011;6(9):e25450.
   PubMed Web of Science ®Google Scholar